Validity and diagnostics of the Reading the Mind in the Eyes Test (RMET) in non-demented amyotrophic lateral sclerosis (ALS) patients.
Reading the Mind in the Eyes Test
amyotrophic lateral sclerosis
diagnostics
executive
psychometric
Journal
Frontiers in psychology
ISSN: 1664-1078
Titre abrégé: Front Psychol
Pays: Switzerland
ID NLM: 101550902
Informations de publication
Date de publication:
2022
2022
Historique:
received:
30
08
2022
accepted:
12
10
2022
entrez:
21
11
2022
pubmed:
22
11
2022
medline:
22
11
2022
Statut:
epublish
Résumé
The aim of this study was to explore the construct validity and diagnostic properties of the Reading the Mind in the Eyes Test (RMET) in non-demented patients with amyotrophic lateral sclerosis (ALS). A total of 61 consecutive patients and 50 healthy controls (HCs) were administered the 36-item RMET. Additionally, patients underwent a comprehensive assessment of social cognition The RMET was solely predicted by the SET-EA ( The RMET is a convergently and divergently valid measure of affective social cognition in non-demented ALS patients, also featuring optimal intrinsic and post-test diagnostic properties in both case-control and case-finding scenarios.
Sections du résumé
Background
UNASSIGNED
The aim of this study was to explore the construct validity and diagnostic properties of the Reading the Mind in the Eyes Test (RMET) in non-demented patients with amyotrophic lateral sclerosis (ALS).
Materials
UNASSIGNED
A total of 61 consecutive patients and 50 healthy controls (HCs) were administered the 36-item RMET. Additionally, patients underwent a comprehensive assessment of social cognition
Results
UNASSIGNED
The RMET was solely predicted by the SET-EA (
Discussion
UNASSIGNED
The RMET is a convergently and divergently valid measure of affective social cognition in non-demented ALS patients, also featuring optimal intrinsic and post-test diagnostic properties in both case-control and case-finding scenarios.
Identifiants
pubmed: 36405135
doi: 10.3389/fpsyg.2022.1031841
pmc: PMC9670302
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1031841Informations de copyright
Copyright © 2022 Aiello, Carelli, Solca, Torre, Ferrucci, Priori, Verde, Silani, Ticozzi and Poletti.
Déclaration de conflit d'intérêts
VS received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., and Novartis Pharma AG, receives or has received research supports from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call. He is in the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Diseases, and Frontiers in Neurology. BP received compensation for consulting services and/or speaking activities from Liquidweb S.r.l. She is Associate Editor for Frontiers in Neuroscience. NT received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. He is Associate Editor for Frontiers in Aging Neuroscience. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor declared a past co-authorship with the authors VS and BP.
Références
Cortex. 2017 Mar;88:1-7
pubmed: 28002755
Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):489-498
pubmed: 27219526
Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):467-472
pubmed: 27152765
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
Amyotroph Lateral Scler Frontotemporal Degener. 2022 Aug;23(5-6):462-469
pubmed: 34907827
J Clin Neurosci. 2020 Jul;77:17-24
pubmed: 32389547
Neurol Sci. 2015 Oct;36(10):1907-12
pubmed: 26072203
Neuropsychology. 2011 Jan;25(1):53-65
pubmed: 20919762
Restor Dent Endod. 2013 Feb;38(1):52-4
pubmed: 23495371
Cortex. 2016 Aug;81:162-7
pubmed: 27236371
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):153-174
pubmed: 28054827
Neurol Sci. 2017 Feb;38(2):303-309
pubmed: 27844173
J Neurol Sci. 1999 Oct 31;169(1-2):13-21
pubmed: 10540002
Cogn Neuropsychiatry. 2013 Jul;18(4):326-54
pubmed: 23106125
Neurology. 2006 Jan 24;66(2):265-7
pubmed: 16434671
Ann Clin Transl Neurol. 2017 Apr 11;4(5):305-317
pubmed: 28491898
PLoS One. 2016 Aug 24;11(8):e0160850
pubmed: 27556398
Cogn Neuropsychiatry. 2017 May;22(3):233-253
pubmed: 28288549
J Neurol. 2015 Jul;262(7):1681-90
pubmed: 25957636
Amyotroph Lateral Scler Frontotemporal Degener. 2020 Aug;21(5-6):380-388
pubmed: 32501122
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
J Neurol Neurosurg Psychiatry. 2015 Nov;86(11):1208-15
pubmed: 25476003
Front Psychol. 2016 Dec 12;7:1934
pubmed: 28018269
Brain Sci. 2021 Oct 15;11(10):
pubmed: 34679420
Patient Relat Outcome Meas. 2020 Sep 22;11:181-194
pubmed: 33061727
Expert Rev Neurother. 2020 Mar;20(3):281-293
pubmed: 32031423
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):21-9
pubmed: 23586919
J Child Psychol Psychiatry. 2001 Feb;42(2):241-51
pubmed: 11280420
Brain. 2012 Mar;135(Pt 3):847-52
pubmed: 22271664
Neurol Sci. 2007 Apr;28(2):80-6
pubmed: 17464470
Eur J Neurol. 2022 Aug;29(8):2211-2219
pubmed: 35524505
Arch Clin Neuropsychol. 2022 Jul 19;37(5):929-938
pubmed: 35107132
Biomed Res Int. 2018 Sep 13;2018:4283427
pubmed: 30302338
Front Psychol. 2020 Aug 21;11:2083
pubmed: 32973626
PLoS One. 2016 Aug 11;11(8):e0161034
pubmed: 27513746
Neurodegener Dis Manag. 2020 Dec;10(6):397-407
pubmed: 32867586